Gynae BT 2017

Low risk endometrial cancer

Surgery alone

• TLH-BSO • no lymphadenectomy, no RT • 95% relapse-free survival

➢ No vaginal brachytherapy : Randomized trial, vaginal recurrence rate: • Vaginal brachytherapy: 0-2% • No additional therapy: 2-5%

Poulsen 1996; Mariani 2000 / 2008; Eltabbakh 1997; Webb 2000; Sorbe et al, 2009